Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 2 of 63 for:    colon cancer AND Rectal | ( Map: New Jersey, United States )

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006269
Recruitment Status : Terminated
First Posted : May 24, 2004
Last Update Posted : May 25, 2012
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 1999
Study Completion Date : No date given